Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo
Wolfgang E. Gallwitz, Theresa A. Guise, Gregory R. Mundy
Wolfgang E. Gallwitz, Theresa A. Guise, Gregory R. Mundy
View: Text | PDF
Article Development

Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo

  • Text
  • PDF
Abstract

Research Article

Authors

Wolfgang E. Gallwitz, Theresa A. Guise, Gregory R. Mundy

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
(a) Effects of 6-thioguanine on PTHrP content in the media of cultured R...
(a) Effects of 6-thioguanine on PTHrP content in the media of cultured RWGT2 cells plated onto 48-well plates and grown to near confluence. Cells were washed and treated with serum-free media containing 6-thioguanine in the indicated concentrations for 48 hours. PTHrP concentrations in conditioned media were corrected for cell number. The detection limit of the assay is ∼0.5 pM/L. (b) Effects of 6-thioguanosine on PTHrP content in the media of cultured RWGT2 cells plated onto 48-well plates and treated as described in a. (c) Effects of purine on PTHrP content in the media of cultured RWGT2 cells plated onto 48-well plates and treated as described in a. (d) Effects of dexamethasone on PTHrP content in the media of cultured RWGT2 cells plated onto 48-well plates and treated as described in a. Values in all panels represent means ± SEM (n = 3 per group). Ctrl, control. *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts